IPO registrations (S-1, F-1) · Registrants
BIOMIMETIC THERAPEUTICS, INC.
- SEC CIK
- 1138400 · filings on EDGAR ↗
- Former names
- BIOMIMETIC PHARMACEUTICALS INC (2003–2005)
- Registration
- Form S-1, first filed 2006-02-10, last 2007-02-02; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2006-05-12; declared effective 2007-02-08
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 389-A NICHOL MILL LANE, Franklin, TN 37067
- EIN
- 62-1786244
- EDGAR entity type
- operating
- Insiders and CEO pay
- BIOMIMETIC THERAPEUTICS, INC. on the corporate pages
Offering terms
- Final price
- $8.00 per share (424B4 filed 2006-05-12, an initial public offering)
- Shares sold
- 4,600,000
- Gross proceeds
- $36,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BMTI
- Lead underwriters
- Deutsche Bank (1,922,800 shares); Pacific Growth Equities, LLC (1,354,700 shares)
- Syndicate
- First Albany Capital Inc (655,500); A.G. Edwards (437,000); Joseph Gunner & Co (57,500); WBB Securities, LLC (57,500); Stephens (57,500); Avondale Partners (57,500)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIOMIMETIC THERAPEUTICS, LLC Fuzzy (name and state)
- Business registration: BIOMIMETIC THERAPEUTICS, LLC Fuzzy (name and state)
- Form 5500 plan sponsor: BIOMIMETIC THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: BIOMIMETIC THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: BIOMIMETIC THERAPEUTICS, INC. EXACT (CIK (EXACT))
- Person page: Douglas G Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2006-02-10 | S-1 | S-1 (registration) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-000862 ↗ |
| 2006-04-03 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-002642 ↗ |
| 2006-04-26 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003176 ↗ |
| 2006-05-08 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003512 ↗ |
| 2006-05-09 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003570 ↗ |
| 2006-05-09 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003622 ↗ |
| 2006-05-10 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003666 ↗ |
| 2006-05-12 | 424B4 | 424B4 (final prospectus) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-003775 ↗ |
| 2006-12-12 | S-1 | S-1 (registration) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-06-010222 ↗ |
| 2007-01-30 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-07-000488 ↗ |
| 2007-02-02 | S-1/A | S-1/A (amendment) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-07-000626 ↗ |
| 2007-02-08 | S-1MEF | S-1MEF (added securities) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-07-000759 ↗ |
| 2007-02-08 | EFFECT | EFFECT (declared effective) | BIOMIMETIC THERAPEUTICS, INC. | 9999999995-07-000539 ↗ |
| 2007-02-09 | 424B4 | 424B4 (final prospectus) | BIOMIMETIC THERAPEUTICS, INC. | 0000950136-07-000785 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2006-05-10 | S-1/A | registration statement | 104,312 | - | 0 | primary document; shares headline | document ↗ | |||
| 2006-05-12 | 424B4 | final prospectus | $8.00 | 4,600,000 | $36,800,000 | Nasdaq BMTI | 8 | primary document; price sentence, shares headline, proceeds table, underwriting table 8 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BULLOCK LAWRENCE E | Officer | Chief Financial Officer | 17 | 2006–2013 | |
| Caplan Arnold I | Director | 2 | 2006 | ||
| Citron Mark Barry | Officer; Other | Sr. Vice President | 3 | 2006–2007 | |
| Douglas Earl Martin | Officer | General Counsel | 18 | 2006–2012 | |
| Dyrberg Thomas | Director,TenPercentOwner | 4 | 2006–2007 | ||
| Ehrlich Christopher B | Director | 9 | 2006–2013 | ||
| HANHAM ANN | Director,TenPercentOwner | 2 | 2006 | ||
| Hart Charles Edward | Officer | Chief Scientific Officer &VP | 5 | 2006–2008 | |
| Hirsch Steven Neal | Officer | COO & Executive VP | 6 | 2006–2010 | |
| Lynch Samuel Eugene | Director,Officer; Director,Officer,TenPercentOwner | President and CEO | 41 | 2006–2013 | |
| MURPHY JAMES G | Director | 13 | 2006–2013 | ||
| PAPASAN LARRY W | Director | 14 | 2006–2013 | ||
| WATSON DOUGLAS G | Director | 15 | 2006–2013 | person page Fuzzy | |
| Friedlaender Gary E | Director | 22 | 2006–2013 | ||
| Burrill & CO (Biotechnology GP), LLC | TenPercentOwner | 2 | 2006 | ||
| Novo A/S | TenPercentOwner | 35 | 2007–2013 | ||
| FEDERICO CHARLES | Director | 10 | 2007–2013 | ||
| Monsor James A. | Officer | VP - Operations | 6 | 2007–2008 | |
| Pagano Russell P. | Officer | VP, Reg. & Clinical Affairs | 13 | 2008–2013 | |
| Christensen Thorkil K. | Director | 2 | 2009–2013 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BIOMIMETIC THERAPEUTICS, LLC | TN | State business registries | name and state |
| Business registration | BIOMIMETIC THERAPEUTICS, LLC | TN | State business registries | name and state |
| Plan sponsor | BIOMIMETIC THERAPEUTICS, INC. | TN | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | BIOMIMETIC THERAPEUTICS, INC. | TN | Federal spending (USAspending) | name and state |
| Patent assignee | BioMimetic Therapeutics, LLC | TN | Patents (USPTO) | name and state |
| SEC filer | BIOMIMETIC THERAPEUTICS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BioMimetic Therapeutics, Inc. | TN | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | BIOMIMETIC THERAPEUTICS, INC. | EIN (EXACT) | ||
| Person page | Douglas G Watson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, TN first:
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
- EVOME MEDICAL TECHNOLOGIES INC. A1
- Breathe BioMedical Inc. A3
- LEGACY VENTURES INTERNATIONAL INC. A6
- TITAN MEDICAL INC A6
- LIFEPOINT INC A6
- RenovaCare, Inc. AZ
In other datasets, the same topic (Technology) in TN:
- Form D issuer: 1 Vision Media, LLC (Form D private offerings)
- Lobbying client: 360 PRIVACY (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology